Antoni Wiedlocha funded by the EEA Poland-Norway grants
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
From the National Centre for Research and Development in Poland:
Published in major journals, first or last author from Oslo University Hospital.
Bahrami S, Shadrin A, Frei O, O'Connell KS, Bettella F, Krull F, Fan CC, Røssberg JI, Hindley G, Ueland T, Dale AM, Djurovic S, Steen NE, Smeland OB, Andreassen OA(2021) Genetic loci shared between major depression and intelligence with mixed directions of effect Nat Hum Behav(in press) DOI 10.1093/nar/gks1055, PubMed 33462475
Smiseth OA, Aalen JM, Skulstad H(2021) Heart failure and systolic function: time to leave diagnostics based on ejection fraction? Eur Heart J(in press) DOI 10.1093/eurheartj/ehaa979, PubMed 33454774
Liestøl K, Kleppe A, Skrede OJ, De Raedt S, Kerr DJ, Danielsen HE(2021) Deep learning and cancer biomarkers: recognising lead-time bias - Authors' reply Lancet, 397(10270), 194-195 DOI 10.1016/S0140-6736(21)00035-0, PubMed 33453777